Every SEC Form 3/4/5 on record for this filer (CIK 1234346) — 2 issuers, 28 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Director | 2018-01-02 → 2026-06-08 | 20 | — |
| ENTX | Entera Bio Ltd. | Director | 2022-01-11 → 2026-01-02 | 15 | $97,851 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| ENTX | 2023-12-22 | Buy | 23,952 | $0.71 | $17,006 | 226,961 |
| ENTX | 2023-08-21 | Buy | 20,000 | $0.59 | $11,800 | 214,209 |
1 of 2 issuers are covered and open a security page; the rest are on file here only.